Perseverance Research Center

Scottsdale, Arizona 85254

2 studies enrolling now · 16 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Dementia, Alzheimer Disease, Atopic Dermatitis, COVID-19, Cerebrovascular Stroke, Late Onset Alzheimer Disease, Migraine, Mild Cognitive Impairment, Multiple Sclerosis (MS) Primary Progressive, Neurodegenerative Diseases, Obesity

Studies at this site

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. — Recruiting now
• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis — Recruiting now
• Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease — Running, not enrolling
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis — Stopped early
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) — Running, not enrolling
• Memory Improvement Through Nicotine Dosing (MIND) Study — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• A Study of LY3437943 in Participants Who Have Obesity or Are Overweight — Completed
• Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB) — Completed
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 — Status unconfirmed